Teladoc Health, Inc.·4

Mar 7, 4:04 PM ET

GOLDSTEIN MICHAEL 4

4 · Teladoc Health, Inc. · Filed Mar 7, 2019

Insider Transaction Report

Form 4
Period: 2019-03-05
Transactions
  • Exercise/Conversion

    Common Stock

    2019-03-05$8.71/sh+20,500$178,55521,418 total
  • Sale

    Common Stock

    2019-03-05$63.33/sh10,500$664,96510,918 total
  • Sale

    Common Stock

    2019-03-05$63.47/sh10,000$634,700918 total
  • Exercise/Conversion

    Stock Option (right to buy)

    2019-03-0520,50013,105 total
    Exercise: $8.71Exp: 2025-02-25Common Stock (20,500 underlying)
Footnotes (3)
  • [F1]Represents the weighted average price of transactions ranging from $63.25 to $63.61. The reporting person undertakes to provide, upon request by the SEC staff, the issuer or any security holder of the issuer, full information regarding the number of shares sold at each separate price.
  • [F2]Represents the weighted average price of transactions ranging from $63.39 to $63.56. The reporting person undertakes to provide, upon request by the SEC staff, the issuer or any security holder of the issuer, full information regarding the number of shares sold at each separate price.
  • [F3]The option vested as to 25% of the shares on February 25, 2016. The remainder of the shares vested in 36 equal monthly installments thereafter.

Documents

1 file
  • 4
    edgar.xmlPrimary

    FORM 4 -